{
    "nct_id": "NCT02415257",
    "official_title": "Gentamicin Treatment Prior to Vestibular Schwannoma Surgery in Patients With no Measurable Remaining Vestibular Function",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Vestibular schwannoma advised to surgical treatment\n* No measurable remaining vestibular function\n\nExclusion Criteria:\n\n* impaired decision making\n* neurofibromatosis\n* signs for central dysfunction\n* remaining vestibular function\n* Patients are advised not to participate in the gentamicin arm if\n* hearing is better than 30 deciBel (dB) in pure tone average (500, 1000, 2000, 3-4000 Hz) and speech discrimination better than 70%\n* the neurosurgeon aim at hearing preservation surgery and do not want to risk gentamicin associated hearing loss\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Vestibular schwannoma advised to surgical treatment\n* No measurable remaining vestibular function",
        "exclusion": "* impaired decision making\n* neurofibromatosis\n* signs for central dysfunction\n* remaining vestibular function\n* Patients are advised not to participate in the gentamicin arm if\n* hearing is better than 30 deciBel (dB) in pure tone average (500, 1000, 2000, 3-4000 Hz) and speech discrimination better than 70%\n* the neurosurgeon aim at hearing preservation surgery and do not want to risk gentamicin associated hearing loss"
    }
}